You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 116 No. 3, September 1965 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (49)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Dicloxacillin

In Vitro and Pharmacologic Comparisons With Oxacillin and Cloxacillin

CHARLES F. GRAVENKEMPER, MD; JOHN V. BENNETT, MD; JEAN L. BRODIE, BS; WILLIAM M. M. KIRBY, MD

Arch Intern Med. 1965;116(3):340-345.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE ISOXAZOLYL group of semisynthetic penicillins has been useful in the oral therapy of infections caused by penicillinase-producing staphylococci. Cloxacillin, which is available for general use in Great Britain instead of oxacillin, has in vitro activity similar to oxacillin against the common gram-positive pathogens and is superior to oxacillin in regard to blood levels obtained after oral and intramuscular administration.1-4 Another new isoxazolyl penicillin, dicloxacillin, appears to give even higher blood levels than cloxacillin, and the present report compares various in vitro and pharmacologic properties of dicloxacillin with those of oxacillin and cloxacillin.

Materials and Methods

Cloxacillin and dicloxacillin were supplied as the sodium monohydrate salt in 250 mg capsules and oxacillin as the sodium salt in 500 mg capsules, for oral administration.

Susceptibility testing with standard powders of oxacillin, cloxacillin, and dicloxacillin was performed by a tube dilution method3 for at least ten recently isolated strains each . . . [Full Text PDF of this Article]


Author Affiliations

SEATTLE

From the Department of Medicine, University of Washington School of Medicine. Trainees in Infectious Diseases (Drs. Gravenkemper and Bennett); Technologist (Miss Brodie); and Professor of Medicine (Dr. Kirby).


Footnotes

Received for publication Dec 31, 1964; accepted Feb 3, 1965.

Reprint requests to University of Washington School of Medicine, Seattle, Wash 98105 (Dr. Kirby).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1965 American Medical Association. All Rights Reserved.